New drug combo aims to slow Progeria's effects

This study tests whether adding everolimus to the existing drug lonafarnib can better control progeria, a rare disease that causes rapid aging in children. About 80 children with confirmed progeria will take both pills by mouth. The first part finds the safest dose of everolimus, and the second part checks if the combination improves weight gain and blood vessel health.